Poolbeg Pharma Income Statement

Financials in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021
Period Ending	Jun '24 Jun 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Selling, General & Admin	4.09	3.38	3.06	2.71
Research & Development	1.51	1.68	2.2	0.55
Other Operating Expenses	-0.48	-0.37	-0.28	-0.15
Operating Expenses	5.13	4.69	4.99	3.11
Operating Income	-5.13	-4.69	-4.99	-3.11
Interest & Investment Income	0.51	0.53	0.21	-
EBT Excluding Unusual Items	-4.62	-4.15	-4.78	-3.11
Asset Writedown	-0.35	-0.35	-	-
Pretax Income	-4.98	-4.51	-4.78	-3.11
Income Tax Expense	-0.6	-0.57	-0.09	-
Net Income	-4.38	-3.93	-4.69	-3.11
Net Income to Common	-4.38	-3.93	-4.69	-3.11
Shares Outstanding (Basic)	500	500	500	317
Shares Outstanding (Diluted)	500	500	500	317
Shares Change (YoY)	-	-	57.62%	-
EPS (Basic)	-0.01	-0.01	-0.01	-0.01
EPS (Diluted)	-0.01	-0.01	-0.01	-0.01
EBITDA	-5.11	-4.66	-4.96	-3.09
D&A For EBITDA	0.03	0.03	0.03	0.02
EBIT	-5.13	-4.69	-4.99	-3.11

Source: S&P Global Market Intelligence. Standard template. Financial Sources.